Loading...
Clicks Group Limited
CLCGY•PNK
HealthcareMedical - Pharmaceuticals
$42.99
$0.19(0.44%)
Clicks Group Limited (CLCGY) Financial Performance & Statements
Review Clicks Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
16.57%
↑ 16.57%
Operating Income Growth
15.15%
↑ 15.15%
Net Income Growth
11.80%
↑ 11.80%
Operating Cash Flow Growth
-9.18%
↓ 9.18%
Operating Margin
8.86%
↑ 8.86%
Gross Margin
24.25%
↑ 24.25%
Net Profit Margin
6.03%
↑ 6.03%
ROE
49.25%
↑ 49.25%
ROIC
46.42%
↑ 46.42%
Clicks Group Limited (CLCGY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Clicks Group Limited stock.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $25.28B | $21.80B | $23.16B | $10.81B |
Cost of Revenue | $19.009B | $16.66B | $17.52B | $8.39B |
Gross Profit | $6.27B | $5.15B | $5.64B | $2.42B |
Gross Profit Ratio | $0.25 | $0.24 | $0.24 | $0.22 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $3.96B | $2.52B | $3.66B | $1.18B |
Operating Expenses | $3.96B | $3.29B | $3.66B | $1.44B |
Total Costs & Expenses | $22.97B | $19.95B | $21.18B | $9.83B |
Interest Income | $43.82M | $92.09M | $45.49M | $38.87M |
Interest Expense | $191.90M | $326.28M | $123.24M | $0.00 |
Depreciation & Amortization | $890.67M | $851.62M | $772.35M | $209.94M |
EBITDA | $3.24B | $5.52B | $2.79B | $1.21B |
EBITDA Ratio | $0.13 | $0.25 | $0.12 | $0.11 |
Operating Income | $2.31B | $1.86B | $1.98B | $995.27M |
Operating Income Ratio | $0.09 | $0.09 | $0.09 | $0.09 |
Other Income/Expenses (Net) | -$150.97M | -$123.14M | -$84.62M | -$47.51M |
Income Before Tax | $2.16B | $1.74B | $1.90B | $947.76M |
Income Before Tax Ratio | $0.09 | $0.08 | $0.08 | $0.09 |
Income Tax Expense | $588.77M | $467.98M | $509.74M | $254.87M |
Net Income | $1.57B | $1.27B | $1.39B | $692.89M |
Net Income Ratio | $0.06 | $0.06 | $0.06 | $0.06 |
EPS | $6.58 | $5.32 | $5.70 | $2.85 |
Diluted EPS | $6.58 | $5.32 | $5.70 | $2.85 |
Weighted Avg Shares Outstanding | $238.06M | $238.64M | $243.04M | $242.95M |
Weighted Avg Shares Outstanding (Diluted) | $238.06M | $238.63M | $243.04M | $242.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan